Modified Aromatic DPP-4 Inhibitor Sitagliptin Phosphate from China
Sitagliptin phosphate is a dipeptidyl peptidase-4 inhibitor with modified aromatic structure for diabetes. HTS 2942.00.05.00 applies to this chemically defined drug meeting aromatic criteria. Phosphate salt follows parent compound.
Duty Rate — China → United States
125%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.04.6093.5%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Phosphate salt classification per Chapter Note 5(C)(3)
• Include GLP-1 pathway efficacy data for drug status
• Monitor for enzyme classification conflicts with 3507